MHK Insider Files Form 144 to Sell 10,000 Shares via UBS Europe SE

Rhea-AI Filing Summary

Form 144 Notice for Mohawk Industries, Inc. (MHK) reports a proposed sale of 10,000 shares of common stock through UBS Europe SE in Paris, with an aggregate market value of $1,282,100.00. The filing states there are 62,131,911 shares outstanding and lists an approximate sale date of 08/19/2025. The shares to be sold were acquired through restricted stock vesting under a registered plan: 5,097 shares vested on 03/04/2022 and 5,097 shares vested on 03/04/2023. No securities were reported sold by the seller in the past three months. The filer certifies they are not aware of undisclosed material adverse information about the issuer.

Positive

• Full disclosure of transaction specifics: class, broker, share count, aggregate market value, outstanding shares, and approximate sale date are provided.
• Acquisition details included: vesting dates and quantities for the restricted stock grants are stated.
• No recent sales by the seller in the past three months are reported, simplifying aggregation rules.

Negative

• Limited market context: filing contains no information on why sale is occurring or any trading plan details.
• No indication of Rule 10b5-1 plan or adoption date, so representation about trading plan status is unresolved in the filing.

Insights

Securities Analyst

TL;DR: Insider plans to sell a small block of vested restricted shares worth $1.28M via UBS Europe SE on 08/19/2025.

The filing is a routine Form 144 notice documenting a proposed sale of 10,000 shares by a person who received those shares through restricted stock vesting in 2022 and 2023. The transaction size relative to the issuer's outstanding shares is immaterial (10,000 of 62,131,911). No prior sales in the past three months are reported. This is procedural disclosure required under Rule 144 and contains no new financial results or operational disclosures.

Corporate Governance Expert

TL;DR: Disclosure aligns with Rule 144 requirements; signer affirms no undisclosed material adverse information.

The document properly identifies the acquisition events as restricted stock vesting and gives broker details and market value. The signer makes the statutory representation about material information. There are no indications of unusual trading arrangements or aggregated sales that would suggest a governance or compliance concern based on the provided content.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	UBS EUROPE SE RUE DU COLISEE 39 PARIS I0 75008	10000	1282100.00	62131911	08/19/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/04/2022	Restricted stock vesting under a registered plan	Issuer			5097	03/04/2022	Not Applicable
Common Stock	03/04/2023	Restricted stock vesting under a registered plan	Issuer			5097	03/04/2023	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Mohawk Industries (MHK) Form 144 report?

The filing reports a proposed sale of 10,000 common shares through UBS Europe SE with an aggregate market value of $1,282,100.00 and an approximate sale date of 08/19/2025.

How were the shares being sold by MHK acquired?

The shares were acquired via restricted stock vesting under a registered plan: 5,097 shares vested on 03/04/2022 and 5,097 shares vested on 03/04/2023.

Does the filer report recent sales of Mohawk stock?

The filing states Nothing to Report for securities sold by the person in the past three months.

What broker is handling the proposed sale of MHK shares?

The sale is to be handled by UBS Europe SE, Rue du Colisee 39, Paris.

How large is the block being sold relative to MHK shares outstanding?

The block of 10,000 shares is small relative to the reported 62,131,911 shares outstanding.